BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights

  October 29, 2024

   · 

  18 min read
• Press Releases

  Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio

  October 29, 2024

   · 

  4 min read
• Press Releases

  Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference

  October 29, 2024

   · 

  1 min read
• Press Releases

  PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500

  October 29, 2024

   · 

  6 min read
• Press Releases

  Precision Optics Customer Receives FDA 510(k) Clearance; Accelerates Production Order for POC Single-Use Endoscope Imaging Assembly

  October 29, 2024

   · 

  4 min read
• Press Releases

  Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

  October 29, 2024

   · 

  4 min read
• Press Releases

  THE LEUKEMIA & LYMPHOMA SOCIETY ANNOUNCES REIMAGINED EXECUTIVE LEADERSHIP TEAM

  October 29, 2024

   · 

  5 min read
• Press Releases

  TikkunLev Therapeutics Emerges from Stealth Mode to Develop First-in-Class Precision Therapies for Heart Failure Targeting the Causal Disease Biology of Failing Heart Muscle

  October 29, 2024

   · 

  4 min read
• Press Releases

  Protega Pharmaceuticals Receives FDA Approval for ROXYBOND™ (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain

  October 29, 2024

   · 

  23 min read
• Press Releases

  Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases

  October 29, 2024

   · 

  7 min read